LEXCX
Price
$65.64
Change
-$0.68 (-1.03%)
Updated
Sep 5 closing price
Net Assets
805.94M
VVIAX
Price
$71.19
Change
-$0.24 (-0.34%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

LEXCX vs VVIAX

Header iconLEXCX vs VVIAX Comparison
Open Charts LEXCX vs VVIAXBanner chart's image
Voya Corporate Leaders Trust B
Price$65.64
Change-$0.68 (-1.03%)
VolumeN/A
Net Assets805.94M
Vanguard Value Index Adm
Price$71.19
Change-$0.24 (-0.34%)
VolumeN/A
Net Assets202.84B
LEXCX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LEXCX vs. VVIAX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LEXCX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 203B vs. LEXCX (806M). VVIAX pays higher dividends than LEXCX: VVIAX (2.10) vs LEXCX (1.64). LEXCX was incepted earlier than VVIAX: LEXCX (90 years) vs VVIAX (25 years). LEXCX (0.40) is less costly to investors than VVIAX (0.05). LEXCX has a lower initial minimum investment than VVIAX: LEXCX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.74 vs. LEXCX (-1.53). LEXCX return over 5 years is better than : 82.21 vs. VVIAX (70.16).
LEXCXVVIAXLEXCX / VVIAX
Total Expense Ratio0.400.05800%
Annual Report Gross Expense Ratio0.400.05800%
Fund Existence90 years25 years-
Gain YTD6.2217.85079%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets806M203B0%
Annual Yield % from dividends1.642.1078%
Returns for 1 year-1.537.74-20%
Returns for 3 years31.5036.6186%
Returns for 5 years82.2170.16117%
Returns for 10 years186.63131.61142%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMCX7.560.20
+2.72%
AMC Networks
INMB1.950.03
+1.56%
INmune Bio
ACGLN18.080.19
+1.06%
Arch Capital Group Ltd
ARDX6.52-0.05
-0.76%
Ardelyx
HQY91.48-6.22
-6.37%
HealthEquity